|
1.
|
Balakumar P, Singh AP and Singh M: Rodent
models of heart failure. J Pharmacol Toxicol Methods. 56:1–10.
2007. View Article : Google Scholar
|
|
2.
|
Patten RD and Hall-Porter MR: Small animal
models of heart failure: development of novel therapies, past and
present. Circ Heart Fail. 2:138–144. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Yang HC, Zuo Y and Fogo AB: Models of
chronic kidney disease. Drug Discov Today Dis Models. 7:13–19.
2010. View Article : Google Scholar
|
|
4.
|
Takeshita D, Shimizu J, Kitagawa Y, et al:
Isoproterenol-induced hypertrophied rat hearts: does short-term
treatment correspond to long-term treatment? J Physiol Sci.
58:179–188. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Van Dokkum RP, Eijkelkamp WB, Kluppel AC,
et al: Myocardial infarction enhances progressive renal damage in
an experimental model for cardio-renal interaction. J Am Soc
Nephrol. 15:3103–3110. 2004.PubMed/NCBI
|
|
6.
|
Dikow R, Schmidt U, Kihm LP, et al: Uremia
aggravates left ventricular remodeling after myocardial infarction.
Am J Nephrol. 32:13–22. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Windt WA, Henning RH, Kluppel AC, Xu Y, de
Zeeuw D and van Dokkum RP: Myocardial infarction does not further
impair renal damage in 5/6 nephrectomized rats. Nephrol Dial
Transplant. 23:3103–3110. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Amann K, Wiest G, Zimmer G, Gretz N, Ritz
E and Mall G: Reduced capillary density in the myocardium of uremic
rats - a stereological study. Kidney Int. 42:1079–1085. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Amann K, Tyralla K, Gross ML, et al:
Cardiomyocyte loss in experimental renal failure: prevention by
ramipril. Kidney Int. 63:1708–1713. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Mall G, Rambausek M, Neumeister A, Kollmar
S, Vetterlein F and Ritz E: Myocardial interstitial fibrosis in
experimental uremia - implications for cardiac compliance. Kidney
Int. 33:804–811. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Tsuruoka S, Nishiki K, Wakaumi M, et al:
Chronopharmacology of oxacalcitriol in 5/6 nephrectomized rats.
Life Sci. 75:809–822. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Go AS, Chertow GM, Fan D, McCulloch CE and
Hsu CY: Chronic kidney disease and the risks of death,
cardiovascular events, and hospitalization. N Engl J Med.
351:1296–1305. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Sarnak MJ, Levey AS, Schoolwerth AC, et
al: Kidney disease as a risk factor for development of
cardiovascular disease: a statement from the American Heart
Association Councils on Kidney in Cardiovascular Disease, High
Blood Pressure Research, Clinical Cardiology, and Epidemiology and
Prevention. Hypertension. 42:1050–1065. 2003. View Article : Google Scholar
|
|
14.
|
Wali RK, Wang GS, Gottlieb SS, et al:
Effect of kidney transplantation on left ventricular systolic
dysfunction and congestive heart failure in patients with end-stage
renal disease. J Am Coll Cardiol. 45:1051–1060. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Butler J, Geisberg C, Howser R, et al:
Relationship between renal function and left ventricular assist
device use. Ann Thorac Surg. 81:1745–1751. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Weinfeld MS, Chertow GM and Stevenson LW:
Aggravated renal dysfunction during intensive therapy for advanced
chronic heart failure. Am Heart J. 138:285–290. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Bongartz LG, Cramer MJ, Doevendans PA,
Joles JA and Braam B: The severe cardiorenal syndrome: ‘Guyton
revisited’. Eur Heart J. 26:11–17. 2005.
|
|
18.
|
Ronco C, Haapio M, House AA, Anavekar N
and Bellomo R: Cardiorenal syndrome. J Am Coll Cardiol.
52:1527–1539. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Bongartz LG, Braam B, Verhaar MC, et al:
Transient nitric oxide reduction induces permanent cardiac systolic
dysfunction and worsens kidney damage in rats with chronic kidney
disease. Am J Physiol Regul Integr Comp Physiol. 298:R815–R823.
2010. View Article : Google Scholar
|
|
20.
|
Rajaram V and Joseph J: Role of adenosine
antagonism in the cardio-renal syndrome: pathophysiology and
therapeutic potential. Curr Heart Fail Rep. 4:153–157. 2007.
View Article : Google Scholar : PubMed/NCBI
|
